Clinical evaluation of a new non-depolarising muscle relaxant.
D000136:Acid-Base Equilibrium / Q000187:drug effects; D001285:Atropine / Q000494:pharmacology; D001391:Azo Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007429:Intraocular Pressure / Q000187:drug effects; D007442:Intubation, Intratracheal; D009119:Muscle Contraction / Q000187:drug effects; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D010197:Pancuronium / Q000494:pharmacology; D010313:Partial Pressure; D011726:Pyridinium Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013997:Time Factors
D001391:Azo Compounds; D007093:Imidazoles; D003473:Neuromuscular Nondepolarizing Agents; D011726:Pyridinium Compounds; D002245:Carbon Dioxide; D009388:Neostigmine; D001285:Atropine; D010197:Pancuronium; D010100:Oxygen